awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58692202-582FB498-A7E1-4F47-B5C7-B50095EDB081
Q58692202-582FB498-A7E1-4F47-B5C7-B50095EDB081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58692202-582FB498-A7E1-4F47-B5C7-B50095EDB081
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts
P2860
Q58692202-582FB498-A7E1-4F47-B5C7-B50095EDB081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58692202-582FB498-A7E1-4F47-B5C7-B50095EDB081
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d1b8f24d4977e821396c8d02e744ad4350003c84
P2860
Advances in immunotherapy for the treatment of glioblastoma.